Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan as Adjunctive Therapy to Inhaled Nitric Oxide in Newborns with PPHN
NCT01389856Phase 3Terminated
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Dec 2011
- Primary completion
- Dec 2013
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
01
Overview
A Phase 3 trial of bosentan in persistent pulmonary hypertension of the newborn (PPHN), sponsored by Actelion Pharmaceuticals Ltd. Started Dec 2011; status: terminated.
02
Drugs
bosentan
03
Conditions
persistent pulmonary hypertension of the newborn (PPHN)
Beyond the preview
Go deeper on NCT01389856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01389856.